4 January 2025

Join Fox News to access this content

Plus special access to select articles and other premium content in your account – for free.

By entering your email and clicking “Continue,” you agree to the Fox News terms of use and privacy policywhich includes our Financial Incentive Notice.

Please enter a valid email address.

2024 brought some major ones Advances in medicine.

This includes approval of “breakthrough” drugs such as Tryvio to treat high blood pressure, Neffy to treat severe allergies, and Dupixent to treat chronic obstructive pulmonary disease (COPD), all of which received FDA approval this year.

These medications “It is set to have a significant clinical impact for those who need it,” according to GoodRx, a California-based digital healthcare platform.

How are prescription medications named? A drug development expert shares the process

Earlier this month, GoodRx released a list of the 19 most influential drugs Vaccine approvals For 2024, some are newly designed to treat specific conditions and other existing drugs are approved for additional uses.

A scientist uses a microscope for analysis in the laboratory

GoodRx created its list by prioritizing “first-in-class medicines and vaccines that are expected to have a significant impact on human health.” (Istock)

Below is the list in order of FDA approval date.

1. Dupixent – Additional use: Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)

2. I am satisfied – New medicine: Advanced skin cancer

3. Xolair – Additional use: food allergies

7 of the most Googled health questions in 2024 with expert answers

4. Wegs -Additional use: Reducing cardiovascular risks

5. Trivio – New medicine: high blood pressure

6. Nexlitol – Additional use: High cholesterol

Close-up of hands organizing medications in daily pill organizer

Some drugs offer new treatments for common conditions, such as Tryvio for high blood pressure and Nextolol for high cholesterol. (Istock)

7. Winrevair – New drug: Pulmonary arterial hypertension

8. mRESVIA – New vaccine: RSV

9. Capaxiv – New vaccine: pneumococcal disease

10. Wakex – Additional use: narcolepsy in children

5 major discoveries about Alzheimer's disease that scientists will reach in 2024

11. dangerous – New medicine: chronic obstructive pulmonary disease

12. Kitty – New medicine: Alzheimer's disease

13. Fukuyzna -Additional use: Heartburn caused by non-erosive esophageal reflux disease (gastroesophageal reflux disease)

A medical professional who prepares a vaccine or treatment injection

Some newly approved drugs are given by injection, such as Kesonla for Alzheimer's and Dupixent. (Istock)

14. Zoneville – New medicine: Alzheimer's disease

15. urvipath – New medication: hypoparathyroidism (low parathyroid hormone levels)

For more health articles, visit www.foxnews.com/health

16. Navy – New medication: severe Allergic reactions

17. FluMist -Additional use: Self or caregiver administration

Click here to subscribe to our health newsletter

18. COPENFI – New medicine: schizophrenia

19. Dupixent – Additional use: chronic obstructive pulmonary disease

A woman uses nasal spray in her bedroom

Many of the newly approved medications are nasal sprays, such as FluMist, a nasal spray vaccine that helps prevent influenza, and Neffy, which is used to treat life-threatening allergies. (Istock)

In its disclaimer, GoodRx noted that the list was created by prioritizing “first-in-class medications and vaccines that are expected to have a significant impact on health.” Human health“.

“This was defined as either the number of lives touched or the degree of impact expected on future recipients of the drug,” the company wrote.

“We also prioritized medicines with efficacy or safety data that represent a significant advantage over other medicines recommended by clinical treatment guidelines or primary medical organizations.”

CLICK HERE TO GET THE FOX NEWS APP

Fox News Digital has reached out to GoodRx for comment.

Leave a Reply

Your email address will not be published. Required fields are marked *